A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects

Summary

The purpose of this study is to evaluate the efficacy and safety of molidustat in peritoneal dialysis subjects with renal anemia

Timeline

Start

2018-02-22

Primary completion

2019-07-25

Completion

2019-07-29

Publications

• Akizawa T, Taguchi M, Matsuda Y, Iekushi K, Yamada T, Yamamoto H. Molidustat for the treatment of renal anaemia in patients with dialysis-dependent chronic kidney disease: design and rationale of three phase III studies. BMJ Open. 2019 Jun 14;9(6):e026602. doi: 10.1136/bmjopen-2018-026602.

Drugs

Indications